Lysosome-derived biomarkers for predicting survival outcome in acute myeloid leukemia
Abstract Lysosomes have a tight connection to cancer and can eliminate cancer cells. The dismal prognosis of acute myeloid leukemia (AML) patients may thus be improved by a thorough examination of the function of lysosome-related genes (LRGs). By using a variety of machine learning methods including...
Saved in:
| Main Authors: | Gongchang Li, Yangyang Miao, Fang Yuan, Weiran Zhang, Yali Wu, Liqiang Zhu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-08-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-03302-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CEBPA mutation in acute myeloid leukemia: prognostic impact of bZIP domain mutation
by: Roy Raj, et al.
Published: (2024-10-01) -
Clinical impact of c-KIT and CEBPA mutations in 33 patients with corebinding factor (Non-M3) acute myeloid leukemia
by: Xiaoyan Mao, et al.
Published: (2023-07-01) -
The role and mechanism of CHMP4C in poor prognosis and drug sensitivity of lung adenocarcinoma
by: Chuan Xu, et al.
Published: (2025-03-01) -
Identification of HOXA9 methylation as an epigenetic biomarker predicting prognosis and guiding treatment choice in acute myeloid leukemia
by: Fei Xie, et al.
Published: (2025-02-01) -
CHMP6 as a novel prognostic biomarker in bladder cancer: insights from a comprehensive cell death-related gene risk model
by: Wei Ning, et al.
Published: (2025-06-01)